february, 2022


Event Details

Clonality testing is at present an established tool in the diagnosis of malignant lymphomas. Between 5-15% of samples submitted to pathology laboratories which are suspected to be malignant lymphomas can benefit from clonality testing, provided that this is performed in laboratories with sufficient expertise. At the moment many laboratories throughout the world are introducing the technology, resulting in questions on pitfalls in technique and the interpretation of the results.

Therefore the EuroClonality/BIOMED-2 consortium decided to organize annual workshops as a service for laboratories that have introduced clonality testing using the EuroClonality/BIOMED-2 primers sets in order to further improve the quality and reliability of the technique in routine practice. Since the vision of the EuroClonality/BIOMED-2 consortium is that clonality testing can be performed only reliably in case of close interaction between the molecular biologist and the (hemato)pathologist, these educational workshops are organized for such partners and are based on interprofessional learning.


(Monday) 09:00 - 23:00



Reacties zijn gesloten.